SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Exactech (EXAC)
EXAC 49.250.0%Feb 14 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert G. Harrell who wrote (21)4/3/1997 12:14:00 PM
From: B.D.   of 118
 
If I read the Annual Report's asset numbrs correctly, EXAC has about $7 million cash and short-term investments. That works out to about $1.45 a share.

This morning, EXAC is trading at $6/share. Minus the cash component, EXAC is trading at $4.55 a share.

The question is, given EXAC's rate of growth, is this a bargain or is EXAC still overpriced? I'm leaning toward the former.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext